PMC:7534795 / 87845-88211
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T436 | 87-100 | Body_part | denotes | cell membrane | http://purl.org/sig/ont/fma/fma63841 |
| T437 | 87-91 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T438 | 124-128 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T604 | 60-62 | http://purl.obolibrary.org/obo/CLO_0001627 | denotes | AA |
| T605 | 87-91 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T606 | 92-100 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
| T607 | 124-128 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T693 | 25-30 | Chemical | denotes | PUFAs | http://purl.obolibrary.org/obo/CHEBI_26208 |
| T694 | 60-62 | Chemical | denotes | AA | http://purl.obolibrary.org/obo/CHEBI_15843|http://purl.obolibrary.org/obo/CHEBI_72816 |
| T696 | 68-71 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T697 | 76-79 | Chemical | denotes | DHA | http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005 |
| T701 | 252-262 | Chemical | denotes | metabolite | http://purl.obolibrary.org/obo/CHEBI_25212 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T205 | 141-159 | http://purl.obolibrary.org/obo/GO_0006950 | denotes | response to stress |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T578 | 0-366 | Sentence | denotes | Supplementation with n-3 PUFAs leads to the substitution of AA with EPA and DHA in the cell membrane which can alter immune cell reaction in response to stress stimuli by shifting the metabolic profile to less proinflammatory or even anti-inflammatory metabolite predominance (Brouard & Pascaud, 1990; Faber et al., 2011; Gibney & Hunter, 1993; Grando et al., 2009). |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33031856-2123401-84039047 | 296-300 | 2123401 | denotes | 1990 |
| 33031856-21430245-84039048 | 316-320 | 21430245 | denotes | 2011 |
| 33031856-8491162-84039049 | 339-343 | 8491162 | denotes | 1993 |
| 33031856-19466285-84039050 | 360-364 | 19466285 | denotes | 2009 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2483 | 21-30 | Chemical | denotes | n-3 PUFAs | MESH:D015525 |
| 2484 | 68-71 | Chemical | denotes | EPA | MESH:D015118 |
| 2485 | 76-79 | Chemical | denotes | DHA | MESH:D004281 |